Tag: gastroretentive drug delivery systems outsourcing market analysis

Uncover key drivers, emerging technologies, and competitive movements shaping the gastroretentive drug delivery systems outsourcing market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Gastroretentive Drug Delivery Systems Outsourcing Market show for the 2026–2030 period?

The gastroretentive drug delivery systems outsourcing market has experienced significant growth in recent years. It is projected to expand from $1.49 billion in 2025 to $1.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. The growth observed in the historical period can be attributed to various factors, including the limitations of conventional oral drug delivery methods, the increasing availability of contract research organization (CRO) services, the demand for improved drug absorption, the expansion of pharmaceutical pipelines, and advancements in formulation technology.

The gastroretentive drug delivery systems outsourcing market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $2.1 billion, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is fueled by several factors, including the proliferation of complex drug molecules, a rising need for patient-focused delivery systems, the broadening of outsourcing approaches, advancements in gastroretentive technologies, and pharmaceutical companies’ pursuit of cost efficiencies. Key trends expected within this period encompass the increasing reliance on external partners for advanced drug delivery development, a heightened requirement for extended GI retention formulations, the growing popularity of floating drug delivery systems, an increase in CRO collaborations for formulation development, and a strong emphasis on improving drug bioavailability.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

What Drivers Are Shaping The Development Of The Gastroretentive Drug Delivery Systems Outsourcing Market?

The increasing occurrence of gastrointestinal ailments is anticipated to fuel the expansion of the gastroretentive drug delivery systems outsourcing market in the future. These ailments encompass a broad spectrum of conditions impacting the digestive system, specifically the stomach, liver, gallbladder, intestines, and pancreas. Several factors contribute to the rise in gastrointestinal disorders, including aging populations, antibiotic usage, infectious agents, dietary shifts, stress, lifestyle choices, and obesity. By outsourcing gastroretentive drug delivery systems, pharmaceutical firms gain access to the necessary resources and specialized knowledge to manage the increasing burden of gastrointestinal disorders, thereby enhancing patient health and overall quality of life. As an illustration, in August 2023, the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based government-funded research institute and public health agency, stated that 60 to 70 million people were affected by various digestive diseases. Consequently, the growing prevalence of gastrointestinal disorders is a key impetus for the gastroretentive drug delivery systems outsourcing market. The expanding occurrence of age-related conditions is projected to stimulate the growth of the gastroretentive drug delivery systems in the future. Age-related disorders denote a wide array of health issues and functional limitations that primarily impact elderly individuals, such as cardiovascular diseases, neurodegenerative disorders, musculoskeletal conditions, and sensory impairments. The rise in these conditions can be attributed to an aging global population, extended life expectancy, various lifestyle factors, and the accumulation of chronic diseases. For example, in April 2025, the Centers for Disease Control and Prevention, a US-based government public health agency, indicated that in 2023, about 194 million American adults, comprising 6 in 10 young adults, 8 in 10 midlife adults, and 9 in 10 older adults, reported having one or more conditions. The prevalence of chronic conditions saw an increase of 7.0 percentage points among young adults. Consequently, the increasing prevalence of age-related disorders is a significant factor propelling the gastroretentive drug delivery systems outsourcing market.

Which Segments Are Contributing To The Growth Of The Gastroretentive Drug Delivery Systems Outsourcing Market?

The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –

1) By Type: Floating Systems, Bioadhesive Systems, Other Types

2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Floating Systems: Single Unit Systems, Multiple Unit Systems

2) By Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers

3) By Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems

What Trends Are Reshaping The Dynamics Of The Gastroretentive Drug Delivery Systems Outsourcing Market?

Key companies within the gastroretentive drug delivery systems outsourcing market are concentrating on developing innovative products, such as ready-to-fill (RTF) colon functional capsules, to enhance drug delivery efficiency and improve patient convenience. The ready-to-fill (RTF) colon functional capsules refer to pre-manufactured, empty capsules intended to be filled with specific formulations or active ingredients designed for the colon. For instance, in September 2024, Evonik, a Germany-based advanced drug delivery provider, introduced EUDRACAP colon functional capsules, which are engineered for the targeted delivery of oral drugs to the ileo-colonic region. These groundbreaking capsules are the first ready-to-fill option accessible in the market, aimed at delivering sensitive active ingredients like live biotherapeutic products (LBPs). Currently offered in technical grade, a GMP-grade product is additionally under development. EUDRACAP colon optimizes the oral drug development process by simplifying formulation and accelerating time to market, making it a substantial advancement in gastroretentive drug delivery systems.

Who Are The Top-Performing Companies In The Gastroretentive Drug Delivery Systems Outsourcing Market In Recent Years?

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, Evonik Industries AG, SGS SA, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

How Does The Gastroretentive Drug Delivery Systems Outsourcing Market Perform Across Major Global Regions?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastroretentive Drug Delivery Systems Outsourcing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp

Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2026, By The Business Research Company

Advanced Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report

Electronic Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Gastroretentive Drug Delivery Systems Outsourcing Industry By 2029?

In recent years, the market size for outsourced gastroretentive drug delivery systems has seen significant growth. The market, which was valued at $1.39 billion in 2024, is projected to increase to $1.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The growth experienced during this historical period is linked to several factors including escalating occurrence of stomach and small intestine disorders, increased usage of drug delivery systems, a higher prevalence of gastric cancer, increased government initiatives, and a rise in hospital numbers.

The market size of gastroretentive drug delivery systems outsourcing is projected to experience significant expansion in the coming years, reaching an estimated value of $1.98 billion in 2029, indicating a compound annual growth rate (CAGR) of 7.4%. This projected growth during the forecast period can be linked to numerous factors such as the surging number of ambulatory centers, enhanced focus on patient compliance and convenience, a rising prevalence of chronic diseases, the expansion of personalized medicine and an increase in the elderly population. Key trends set to predominately feature in the forecast period include improvements in polymer science, techniques of formulation, bioadhesive processes, innovative polymers, modifiers for drug release, the creation of gastroretentive dosage forms, the incorporation of digital health technologies, intelligent gastroretentive systems, and focused drug delivery.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

Which Factors Are Steering Growth In The Gastroretentive Drug Delivery Systems Outsourcing Market?

The surge in gastrointestinal disorders is projected to drive the growth of the gastroretentive drug delivery systems outsourcing market. These disorders encompass a broad spectrum of diseases that impact the digestive tract, including the stomach, liver, gallbladder, intestines, and pancreas. Factors such as an aging population, antibiotic use, infectious agents, changes in diet, stress and lifestyle factors, and obesity contribute to the increase in gastrointestinal disorders. The outsourcing of gastroretentive drug delivery systems offers pharmaceutical firms the necessary resources and proficiency to contend with the mounting burden of gastrointestinal disorders, ultimately enhancing patient results and quality of life. For instance, data from the American Cancer Society (ACS), a US-based health organization dedicated to eradicating cancer, showed that gastrointestinal cancers rose by 3.18% to 348,840 in January 2023 from 338,090 in 2021 in the US. Thus, the upswing in gastrointestinal disorders is stimulating the gastroretentive drug delivery systems outsourcing market.

Which Segment Accounts For The Largest Share In The Gastroretentive Drug Delivery Systems Outsourcing Market?

The gastroretentive drug delivery systems outsourcingmarket covered in this report is segmented –

1) By Type: Floating Systems; Bioadhesive Systems; Other Types

2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications

4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users

Subsegments:

1) Floating Systems: Single Unit Systems; Multiple Unit Systems

2) Bioadhesive Systems: Hydrogels; Mucoadhesive Polymers

3) Other Types: Magnetically Assisted Systems; High-Density Systems; Osmotic Systems

Which Long-Term Trends Will Play A Crucial Role In The Gastroretentive Drug Delivery Systems Outsourcing Market?

Prominent firms active in the gastroretentive drug delivery systems outsourcing industry are concentrating on the creation of ground-breaking products such as ready-to-fill (RTF) colon functional capsules. These innovations aim to boost drug delivery competence and convenience for patients. RTF colon functional capsules are essentially pre-produced, empty capsules devised to carry specially designed formulations or active components targeted at the colon. An example of this innovative approach is Evonik’s EUDRACAP colon functional capsules, which were launched in September 2024. Evonik is a German company recognised for its breakthroughs in drug delivery. These pioneering capsules, created for the targeted delivery of oral medications to the ileo-colonic region, are currently the first of their kind RTF alternatives on the market. They are primarily used for transferring delicate active components like live biotherapeutic products (LBPs). While currently available in a technical grade, a GMP-grade version is also under development. The EUDRACAP colon has simplified the oral drug development procedure and fast-tracked the time to market, marking a remarkable progress in gastroretentive drug delivery systems.

Who Are The Dominant Players In The Gastroretentive Drug Delivery Systems Outsourcing Market Today?

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

What Regional Factors Are Accelerating Growth In The Gastroretentive Drug Delivery Systems Outsourcing Market?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp

Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Nasal Drug Delivery Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nasal-drug-delivery-technology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Gastroretentive Drug Delivery Systems Outsourcing Industry Compare Between 2025 And 2029?

The market for gastroretentive drug delivery systems outsourcing has seen robust expansion in recent years. This market is set to increase from $1.39 billion in 2024 to $1.49 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%. Key drivers for this historical growth include an escalating incidence of stomach and small intestine disorders, advancements in drug delivery systems, a higher prevalence of gastric cancer, an increase in government initiatives, and a greater number of hospitals.

The gastroretentive drug delivery systems outsourcing market is poised for significant expansion in the coming years. This market is forecasted to reach $1.98 billion by 2029, propelled by a compound annual growth rate (CAGR) of 7.4%. This projected growth stems from several factors, including an increase in ambulatory centers, a heightened focus on patient compliance and convenience, the rising occurrence of chronic diseases, the growth of personalized medicine, and an expanding aging population. Prominent trends for the forecast period involve advancements in polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the evolution of gastroretentive dosage forms, the integration of digital health technologies, smart gastroretentive systems, and targeted drug delivery.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

What Are The Key Drivers Of Growth In The Gastroretentive Drug Delivery Systems Outsourcing Market?

The increasing occurrence of gastrointestinal disorders is projected to propel the expansion of the gastroretentive drug delivery systems outsourcing market in the coming years. These disorders encompass a broad spectrum of diseases that affect the digestive tract, including the stomach, liver, gallbladder, intestines, and pancreas. The rise in gastrointestinal disorders is attributed to factors such as aging populations, antibiotic use, infectious agents, dietary shifts, stress, various lifestyle factors, and obesity. Outsourcing gastroretentive drug delivery systems offers pharmaceutical companies the necessary resources and specialized knowledge to address the escalating burden of these conditions, ultimately enhancing patient outcomes and their quality of life. For instance, in January 2023, the American Cancer Society (ACS), a US-based health organization dedicated to eliminating cancer, reported that gastrointestinal cancers increased by 3.18% to 348,840 cases in the United States, up from 338,090 in 2021. Thus, the growing prevalence of gastrointestinal disorders is significantly driving the gastroretentive drug delivery systems outsourcing market.

What Are The Different Segment Classifications Within The Gastroretentive Drug Delivery Systems Outsourcing Market?

The gastroretentive drug delivery systems outsourcingmarket covered in this report is segmented –

1) By Type: Floating Systems; Bioadhesive Systems; Other Types

2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications

4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users

Subsegments:

1) Floating Systems: Single Unit Systems; Multiple Unit Systems

2) Bioadhesive Systems: Hydrogels; Mucoadhesive Polymers

3) Other Types: Magnetically Assisted Systems; High-Density Systems; Osmotic Systems

How Are Trends Influencing The Gastroretentive Drug Delivery Systems Outsourcing Market?

Major companies within the gastroretentive drug delivery systems outsourcing market are concentrating on creating innovative products, such as ready-to-fill (RTF) colon functional capsules, to boost drug delivery efficiency and patient ease. Ready-to-fill (RTF) colon functional capsules refer to pre-manufactured, empty capsules specifically designed to be filled with particular formulations or active ingredients tailored for the colon. For instance, in September 2024, Evonik, a Germany-based leader in advanced drug delivery, unveiled EUDRACAP colon functional capsules, engineered for the targeted administration of oral drugs to the ileo-colonic region. These innovative capsules are the first ready-to-fill option introduced to the market, intended for delivering sensitive active ingredients like live biotherapeutic products (LBPs). Currently available in technical grade, a GMP-grade product is also being developed. EUDRACAP colon improves the oral drug development process by simplifying formulation and expediting time to market, positioning it as a significant stride in gastroretentive drug delivery systems.

Which Major Industry Participants Are Leading The Gastroretentive Drug Delivery Systems Outsourcing Market Growth?

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

Which Geographies Are Emerging As Strong Markets For The Gastroretentive Drug Delivery Systems Outsourcing Industry?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Gastroretentive Drug Delivery Systems Outsourcing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp

Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2025, By The Business Research Company

Gastric Cancer Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Nasal Drug Delivery Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nasal-drug-delivery-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Gastroretentive Drug Delivery Systems Outsourcing Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent years, the market size for outsourced gastroretentive drug delivery systems has seen substantial growth. The market is predicted to increase from $1.39 billion in 2024 to $1.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period is due to several factors including an increase in stomach and small intestine disorders, an upturn in drug delivery systems, a surge in gastric cancer cases, increased government initiatives, and a rise in the number of hospitals.

In the coming years, the outsourcing market for gastroretentive drug delivery systems is projected to experience robust growth. The market is anticipated to reach $1.98 billion by 2029, progressing at a Compound Annual Growth Rate (CAGR) of 7.4%. Factors driving this growth during the prediction period include an upsurge in ambulatory centers, prioritization of patient compliance and convenience, the escalating occurrence of chronic diseases, the surge in personalized medication, and expanding elderly population. Key trends for the forecast period encompass advancements in polymer science, evolutions in formulation technologies and bioadhesive systems, the introduction of novel polymers and drug release modifiers, the creation of gastroretentive dosage forms, the incorporation of digital health technologies, intelligent gastroretentive systems, and targeted drug delivery.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Gastroretentive Drug Delivery Systems Outsourcing Market?

Increasing incidences of gastrointestinal diseases are projected to boost the expansion of the gastroretentive drug delivery systems outsourcing market in the future. Gastrointestinal disorders encompass various ailments that affect the digestive system, including the stomach, liver, gallbladder, intestines, and pancreas. The upsurge in these disorders can be attributed to an aging population, the use of antibiotics, infectious diseases, alterations in diet, stress and lifestyle changes, and obesity. By outsourcing gastroretentive drug delivery systems, pharmaceutical firms are able to harness the necessary expertise and resources to combat the rising threat of gastrointestinal disorders, thereby enhancing patient outcomes and their quality of life. For example, in January 2023, the American Cancer Society (ACS), a health organization based in the US and committed to eradicating cancer, reported an increase of 3.18% in gastrointestinal cancers, with the number rising to 348,840 from 338,090 in 2021 within the United States. Consequently, the escalating occurrence of gastrointestinal disorders is fueling the growth of the gastroretentive drug delivery systems outsourcing market.

Which Key Market Segments Comprise the Gastroretentive Drug Delivery Systems Outsourcing Market and Drive Its Revenue Growth?

The gastroretentive drug delivery systems outsourcingmarket covered in this report is segmented –

1) By Type: Floating Systems; Bioadhesive Systems; Other Types

2) By Dosage Form: Tablets; Liquid; Microspheres; Capsule; Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD); Neurological Disorders; Other Applications

4) By End User: Pharmaceutical Companies; Contract Research Organizations (CROs); Other End Users

Subsegments:

1) Floating Systems: Single Unit Systems; Multiple Unit Systems

2) Bioadhesive Systems: Hydrogels; Mucoadhesive Polymers

3) Other Types: Magnetically Assisted Systems; High-Density Systems; Osmotic Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp

Which Areas Are Leading Regions in the Gastroretentive Drug Delivery Systems Outsourcing Market Expansion Across the Globe?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Strategic Trends Steering theGastroretentive Drug Delivery Systems Outsourcing Market Direction?

Leading businesses in the gastroretentive drug delivery systems outsourcing market are concentrating on creating pioneering products such as ready-to-fill (RTF) colon functional capsules. These aim to increase the effectiveness of drug delivery and improve the convenience of patients. RTF colon functional capsules are pre-fabricated, empty capsules ready to be filled with specific formulations or active ingredients for the colon. For instance, in Germany, Evonik, a frontrunner in advanced drug delivery, rolled out their EUDRACAP colon functional capsules in September 2024. These capsules are crafted for the targeted delivery of oral medications to the ileo-colonic region and are the first RTF option on the market intended for delivering sensitive active ingredients like live biotherapeutic products (LBPs). They are currently available in technical grade, with a GMP-grade product in the pipeline. The development of EUDRACAP colon simplifies the formulation and speeds up time to market in the oral drug development process, marking a significant breakthrough in gastroretentive drug delivery systems.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

How Is the Gastroretentive Drug Delivery Systems Outsourcing Market Conceptually Defined?

Gastroretentive drug delivery systems outsourcing refers to the practice of pharmaceutical companies contracting with external service providers or contract research organizations (CROs) to develop and manufacture drug delivery systems designed to prolong the residence time of medications within the gastrointestinal (GI) tract. These systems are engineered to enhance drug absorption, improve therapeutic efficacy, and optimize patient outcomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the gastroretentive drug delivery systems outsourcing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Gastroretentive Drug Delivery Systems Outsourcing Market Through 2034?

The market for outsourcing gastroretentive drug delivery systems has witnessed robust growth recently. The market size is set to expand from $1.39 billion in 2024 to $1.5 billion in 2025, registering a compound annual growth rate (CAGR) of 8.3%. The significant growth in the historical period is due to multiple factors such as the increasing cases of stomach and small intestine diseases, growth in drug delivery systems, a surge in gastric cancer prevalence, an escalation in government initiatives, and a rise in the number of hospitals.

In the coming years, substantial growth is projected for the gastroretentive drug delivery systems outsourcing market. It is predicted to ascend to $2.03 billion in 2029, with a compound annual growth rate (CAGR) of 7.9%. The expected growth within the forecasting period can be attributed to several elements including the rise in the number of ambulatory centers, an emphasis on patient convenience and compliance, an increasing prevalence of chronic diseases, the expansion of personalized medicine, and an aging population. Trends anticipated in the forecast period encompass advancements in multiple areas such as polymer science, formulation technologies, bioadhesive systems, novel polymers, drug release modifiers, the creation of gastroretentive dosage forms, the incorporation of digital health technologies, intelligent gastroretentive systems, and targeted drug delivery.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Gastroretentive Drug Delivery Systems Outsourcing Market?

The increasing incidence of gastrointestinal diseases is anticipated to propel the expansion of the outsourcing market for gastroretentive drug delivery systems. This term encompasses a variety of ailments that affect the digestive system, including the stomach, liver, gallbladder, intestines, and pancreas. The upsurge in gastrointestinal diseases is due to factors such as an aging population, the use of antibiotics, infectious agents, alterations in diet, stress, lifestyle changes, and obesity. Outsourcing of gastroretentive drug delivery systems equips pharmaceutical firms with the necessary resources and expertise to tackle the growing issue of gastrointestinal disorders, thereby enhancing patient results and quality of life. For example, the US-based health organization American Cancer Society (ACS), committed to cancer elimination, recorded a 3.18% increase in gastrointestinal cancers, rising to 348,840 in January 2023 from 338,090 in 2021 in the United States. Thus, the upsurge in gastrointestinal disorders is fuelling the growth of the gastroretentive drug delivery systems outsourcing market.

Which Key Market Segments Comprise the Gastroretentive Drug Delivery Systems Outsourcing Market and Drive Its Revenue Growth?

The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –

1) By Type: Floating Systems, Bioadhesive Systems, Other Types

2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) Floating Systems: Single Unit Systems, Multiple Unit Systems

2) Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers

3) Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Gastroretentive Drug Delivery Systems Outsourcing Market?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Key Market Trends in the Gastroretentive Drug Delivery Systems Outsourcing Market Over the Coming Years?

Prominent businesses in the gastroretentive drug delivery systems outsourcing market are concentrating their efforts on developing unique products like ready-to-fill (RTF) colon functional capsules. These aim to improve drug delivery effectiveness and patient comfort. The RTF colon functional capsules are essentially pre-fabricated empty capsules designed for filling with specific colon-targeted formulations or active ingredients. For example, in September 2024, German advanced drug delivery leader, Evonik, unveiled the EUDRACAP colon functional capsules for targeted oral drug delivery to the ileo-colonic region. These innovative capsules, which are the first RTF options on the market, focus on delivering sensitive active ingredients like live biotherapeutic products (LBPs). The company currently offers a technical grade, with GMP-grade variant under development. The introduction of the EUDRACAP colon is a significant breakthrough in gastroretentive drug delivery systems as it streamlines the formulation procedure and accelerates the market launch time for oral drugs.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

How Is the Gastroretentive Drug Delivery Systems Outsourcing Market Conceptually Defined?

Gastroretentive drug delivery systems outsourcing refers to the practice of pharmaceutical companies contracting with external service providers or contract research organizations (CROs) to develop and manufacture drug delivery systems designed to prolong the residence time of medications within the gastrointestinal (GI) tract. These systems are engineered to enhance drug absorption, improve therapeutic efficacy, and optimize patient outcomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theGastroretentive Drug Delivery Systems Outsourcing Market?

The gastroretentive drug delivery systems outsourcing market is anticipated to be fueled by the increasing instances of gastrointestinal diseases. The term gastrointestinal disorders relates to a broad spectrum of ailments impacting the digestive system, including the organs such as the stomach, liver, gallbladder, intestines, and pancreas. Factors such as an aging population, use of antibiotics, infectious pathogens, changes in diet, stress, lifestyle habits, and obesity are leading to an increase in gastrointestinal disorders. Pharmaceutical firms are resorting to outsourcing gastroretentive drug delivery systems, as it grants them the necessary tools and expertise to handle the escalating burden of these disorders, thereby enhancing patient results and life quality. In the context of growing gastrointestinal disorder cases, for example, the American Cancer Society (ACS), a US-based organization committed to combating cancer, reported that gastrointestinal cancers rose by 3.18% to 348,840 from 338,090 in 2021 in the U.S. in January 2023. Hence, the growing instances of gastrointestinal disorders are pushing the growth of the gastroretentive drug delivery systems outsourcing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

#What Growth Opportunities Will Drive the Gastroretentive Drug Delivery Systems Outsourcing Market’s CAGR Through 2034?

The market size for outsourced gastroretentive drug delivery systems has seen significant expansion lately. The market’s growth is projected to rise from $1.39 billion in 2024 to $1.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. Factors such as an increase in stomach and small intestine diseases, the development of drug delivery systems, growing cases of gastric cancer, governmental initiatives, and the rising number of hospitals contributed to the historical period’s growth.

The market for outsourced gastroretentive drug delivery systems is anticipated to witness robust growth in the coming years, reaching $2.03 billion in 2029 with a compounded annual growth rate of 7.9%. This upcoming growth has been attributed to the increase in ambulatory centers, greater focus on patient compliance and comfort, a surge in chronic diseases, a rise in individualized care, and an increasing aging populace. Key trends during this period are expected to be advancements in polymer science, bioadhesive systems, new polymers, drug release modifiers, and the creation of gastroretentive dosage tactics. Other major predictors include the adoption of digital health technology, intelligent gastroretentive systems, and targeted drug delivery methods.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813

Which Upcoming Market Trends and Innovations Are Set to Influence theGastroretentive Drug Delivery Systems Outsourcing Market’s Path Forward?

Leading enterprises in the gastroretentive drug delivery systems outsourcing market are honing their focus on creating pioneering products like ready-to-fill (RTF) colon functional capsules to boost drug delivery efficacy and patient comfort. This refers to ready-made, unfilled capsules, specifically created to be packed with specific drugs or active components intended for the colon. As an illustration, Evonik, a proficient drug delivery organization from Germany, unveiled their EUDRACAP colon functional capsules in September 2024 for targeted oral drug delivery to the ileo-colonic area. These trailblazing capsules are the maiden ready-to-fill option in the market, with the aim of delivering delicate active components such as live biotherapeutic products (LBPs). Currently sold in technical grade, a GMP-grade variant is also under progression. EUDRACAP colon augments the oral drug development process by easing formulation and expediting market penetration, making it a significant leap in gastroretentive drug delivery systems.

Who Are the Dominant Market Players Pushing the Boundaries of theGastroretentive Drug Delivery Systems Outsourcing Market?

Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

What Are the Core Segments of the Gastroretentive Drug Delivery Systems Outsourcing Market, and How Do They Contribute to Growth?

The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –

1) By Type: Floating Systems, Bioadhesive Systems, Other Types

2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms

3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications

4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) Floating Systems: Single Unit Systems, Multiple Unit Systems

2) Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers

3) Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp

What Regions Are Dominating the Gastroretentive Drug Delivery Systems Outsourcing Market Growth?

North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2025, By The Business Research Company:

Nasal Drug Delivery Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nasal-drug-delivery-technology-global-market-report

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Connected Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: